Structure-activity relationships of stemphones, potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus

Journal of Antibiotics

Volumn 61, Issue 7, 2008, Pages 426-441

  Yamazaki, Hiroyuki ^a   Koyama, Nobuhiro ^a   Omura, Satoshi ^a   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Fungal metabolite; Imipenem potentiator; Methicillin resistant Staphylococcus aureus; MRSA; Stemphones

Indexed keywords

IMIPENEM; NATURAL PRODUCT; STEMPHONE C; STEMPHONE E; STEMPHONE F; STEMPHONE G; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BENZOQUINONE DERIVATIVE; STEMPHONE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ASPERGILLUS; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; CULTURE MEDIUM; DRUG EFFECT; LEUKEMIA CELL LINE; METABOLISM; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

ASPERGILLUS SP.; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ASPERGILLUS; BENZOQUINONES; CULTURE MEDIA; HUMANS; IMIPENEM; JURKAT CELLS; METHICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 55449128704     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.59     Document Type: Article

References (16)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40: 135-136 (1997)
2. Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep 46: 765-766 (1997)
3. Koyama N, Nagahiro T, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S. Stemphones, novel potentiators of imipenem activity against methicillin- resistant Staphylococcus aureus, produced by Aspergillus sp. FKI-2136. J Antibiot 58: 695-703 (2005)
4. Schnur RC, Corman ML, Gallaschun RJ, Cooper BA, Dee MF, Doty JL, Muzzi ML, DiOrio CI, Barbacci EG, Miller PE, Pollack VA, Savage DM, Sloan DE, Pustilnik LR, Moyer JD, Moyer MP. erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. J Med Chem 38: 3813-3820 (1995)
5. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63 (1983)
6. Miyagawa H, Nagai S, Tsurushima T, Sato M, Ueno T, Fukami H. Phytotoxins produced by the plant pathogenic fungus Bipolaris bicolor El-1. Biosci Biotech Biochem 58: 1143-1145 (1994)
7. Lim CH, Miyagawa H, Ueno T, Takenaka H, Tsurusima T. Isolation and structure elucidation of terpenoid phytotoxins produced by the plant pathogenic fungus Bipolaris cynodontis. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 37th: 325-330 (1995)
8. 3H]ivermectin binding sites. J Antibiot 43: 1179-1182 (1990)
9. Lee HB, Lim CH, Kwon HJ, Kim YK, Lee HS, Kim CJ. Inhibitory activity of diacylglycerol acyltransferase by cochlioquinones A and A1. J Antibiot 56: 967-969 (2003)
10. Fujioka T, Yao K, Hamano K, Hosoya T, Kagasaki T, Furukawa Y, Haruyama H, Sato S, Koga T, Tsujita Y. Epi-cochlioquinone A, a novel acyl-CoA:cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi. J Antibiot 49: 409-413 (1996)
11. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45: 1737-1742 (2001)
12. Shimizu M, Shiota S, Mizusbima T, Ito H, Hatano T, Yoshida T, Tsuchiya T. Marked potentiation of activity of beta-lactams against methicillin-resistant Staphylococcus aureus by corilagin. Antimicrob Agents Chemother 45: 3198-3201 (2001)
13. Shiota S, Shimizu M, Mizushima T, Ito H, Hatano T, Yoshida T, Tsuchiya T. Restoration of effectiveness of beta-lactams on methicillin-resistant Staphylococcus aureus by tellimagrandin I from rose red. FEMS Microbiol Lett 185: 135-138 (2000)
14. Shiota S, Shimizu M, Sugiyama J, Morita Y, Mizushima T, Tsuchiya T. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol Immunol 48: 67-73 (2004)
15. Fukumoto A, Kim Y-P, Matsumoto A, Takahashi Y, Shiomi K, Tomoda H, Ōmura S. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation. J Antibiot 61: 1-6 (2008)
16. Fukumoto A, Kim Y-P, Hanaki H, Shiomi K, Tomoda H, Ōmura S. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities. J Antibiot 61: 7-10 (2008)